FDA Drug Application (202014) for NORETHINDRONE by NOVAST LABS LTD

Back to FDA Applications sponsored by NOVAST LABS LTD

Application Number202014
Product Number001
FormTABLET;ORAL-28
Dosage0.35MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNORETHINDRONE
Active IngredientNORETHINDRONE

Active IngredientCount
List of drugs with Active Ingredient NORETHINDRONE82


Back to FDA Applications sponsored by NOVAST LABS LTD